Akebia Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Feb 24 | SellUS$11,327 | Steven Burke | Individual | 7,169 | US$1.58 | |
29 Feb 24 | SellUS$9,439 | Nicole Hadas | Individual | 5,974 | US$1.58 | |
29 Feb 24 | SellUS$13,684 | Michel Dahan | Individual | 8,661 | US$1.58 | |
29 Feb 24 | SellUS$73,581 | John Butler | Individual | 46,570 | US$1.58 | |
27 Feb 24 | SellUS$57,354 | John Butler | Individual | 37,733 | US$1.52 | |
27 Feb 24 | SellUS$16,331 | Michel Dahan | Individual | 10,744 | US$1.52 | |
01 Feb 24 | SellUS$40,842 | Steven Burke | Individual | 24,311 | US$1.68 | |
01 Feb 24 | SellUS$78,102 | John Butler | Individual | 46,489 | US$1.68 | |
25 May 23 | SellUS$116,760 | Michel Dahan | Individual | 95,478 | US$1.22 | |
25 May 23 | SellUS$77,270 | Nicole Hadas | Individual | 63,186 | US$1.22 | |
16 May 23 | SellUS$67,890 | David Spellman | Individual | 63,567 | US$1.07 | |
16 May 23 | SellUS$67,890 | Steven Burke | Individual | 63,567 | US$1.07 |
Insider Trading Volume
Insider Buying: AKBA insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,704 | 0.000814% |
Individual Insiders | 6,046,848 | 2.89% |
VC/PE Firms | 14,202,558 | 6.78% |
Institutions | 38,633,065 | 18.5% |
General Public | 150,488,100 | 71.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
14,202,558 | US$19.3m | -12.4% | 31.39% | |||
7,607,472 | US$10.3m | 1.15% | no data | |||
6,915,503 | US$9.4m | -4.26% | 0.03% | |||
4,779,383 | US$6.5m | 51.5% | 0.01% | |||
3,122,824 | US$4.2m | 27.3% | no data | |||
2,599,987 | US$3.5m | -14.8% | no data | |||
2,159,364 | US$2.9m | 188% | no data | |||
2,002,561 | US$2.7m | 0% | no data | |||
1,856,925 | US$2.5m | 8.02% | 0.01% | |||
1,801,690 | US$2.5m | 4.49% | no data | |||
1,467,811 | US$2.0m | 11.1% | no data | |||
866,554 | US$1.2m | -10.2% | no data | |||
706,932 | US$961.4k | 121% | no data | |||
695,840 | US$946.4k | 157% | no data | |||
673,779 | US$916.3k | 63.6% | no data | |||
663,259 | US$902.0k | 79.1% | no data | |||
620,319 | US$843.6k | -0.61% | no data | |||
610,550 | US$830.3k | -6.99% | no data | |||
579,490 | US$788.1k | -9.18% | no data | |||
310,368 | US$422.1k | 2.73% | no data | |||
305,606 | US$415.6k | 100% | no data | |||
257,173 | US$349.8k | 112% | no data | |||
242,974 | US$330.4k | 0% | no data | |||
200,000 | US$272.0k | 0% | 0.01% | |||
188,594 | US$256.5k | 0% | no data |